KEYBANK NATIONAL ASSOCIATION/OH – BioMarin Pharmaceutical Inc. Transaction History
KEYBANK NATIONAL ASSOCIATION/OH portfolio value:
$42.32M
portfolio value
KEYBANK NATIONAL ASSOCIATION/OH quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.17% | 29.02K shares | 3.35M | $84.77 | 499.26K |
| Q2 2022 | share | Increase | +23.45% | 89.34K shares | 9.60M | $82.87 | 470.24K |
| Q1 2022 | share | Increase | +25.00% | 76.18K shares | 2.44M | $77.1 | 380.9K |
| Q4 2021 | share | Increase | +69.77% | 125.22K shares | 13.04M | $89.08 | 304.71K |
| Q3 2021 | share | Increase | +1.75% | 3.07K shares | -847K | $77.29 | 179.48K |
| Q2 2021 | share | Increase | +10.41% | 16.63K shares | 2.65M | $83.44 | 176.40K |
| Q1 2021 | share | Increase | +143.96% | 94.28K shares | 6.32M | $75.51 | 159.77K |
| Q4 2020 | share | Increase | +448.08% | 53.54K shares | 4.83M | $87.69 | 65.49K |
| Q3 2020 | share | Increase | +20.11% | 2.00K shares | -318K | $76.08 | 11.94K |
| Q2 2020 | share | Increase | +22.09% | 1.8K shares | 538K | $123.34 | 9.94K |
| Q1 2020 | share | Decrease | -15.97% | -1.54K shares | -131K | $84.5 | 8.14K |
| Q4 2019 | share | Increase | 0.00% | 9.69K shares | 820K | $84.55 | 9.69K |
| Q3 2019 | share | Decrease | -100.00% | -3.75K shares | -322K | $67.4 | 0 |
| Q2 2019 | share | Decrease | -41.67% | -2.68K shares | -250K | $85.65 | 3.75K |
| Q1 2019 | share | Decrease | -10.77% | -777 shares | -42K | $88.83 | 6.43K |
| Q4 2018 | share | Increase | +29.27% | 1.63K shares | 73K | $85.15 | 7.21K |
| Q3 2018 | share | Decrease | -47.83% | -5.11K shares | -466K | $96.97 | 5.58K |
| Q2 2018 | share | Increase | +119.03% | 5.81K shares | 611K | $94.2 | 10.69K |
| Q1 2018 | share | Decrease | -21.39% | -1.32K shares | -158K | $81.07 | 4.88K |
| Q4 2017 | share | Decrease | -20.42% | -1.59K shares | -173K | $89.17 | 6.21K |
| Q3 2017 | share | Increase | +57.06% | 2.83K shares | 276K | $93.07 | 7.80K |
| Q2 2017 | share | Decrease | -36.06% | -2.80K shares | -231K | $90.82 | 4.97K |
| Q1 2017 | share | Increase | +32.24% | 1.89K shares | 195K | $87.78 | 7.77K |
| Q4 2016 | share | Increase | +37.05% | 1.58K shares | 90K | $82.84 | 5.87K |
| Q3 2016 | share | Decrease | -17.18% | -890 shares | -6K | $92.52 | 4.28K |
| Q2 2016 | share | Increase | 0.00% | 5.17K shares | 403K | $77.8 | 5.17K |
| Q1 2016 | share | Decrease | -100.00% | -4.6K shares | -482K | $82.48 | 0 |